Polycyclic phenols, estrogens and neuroprotection: A proposed mitochondrial mechanism

Experimental Gerontology

Volumn 38, Issue 1-2, 2003, Pages 101-107

  Dykens, J A ^a   Simpkins, J W ^b   Wang, J ^b   Gordon, K ^a  

^a Migenix Inc   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

Estrogens; Mitochondria; Neuroprotection; Steroids

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

APOPTOSIS; BIOLOGICAL MODEL; BRAIN MITOCHONDRION; CELL PROTECTION; CELL TYPE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MITOCHONDRION SWELLING; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; UPREGULATION;

ADENOSINE TRIPHOSPHATE; AGING; ANTICONVULSANTS; APOPTOSIS; CALCIUM; CELL MEMBRANE PERMEABILITY; ESTRADIOL; HUMANS; MITOCHONDRIA; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPROTECTIVE AGENTS; NITRO COMPOUNDS; PHENOLS; PROPIONIC ACIDS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 12244282418     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00162-6     Document Type: Conference Paper

References (47)

1. Azcoitia I., Sierra A., Garcia-Segura L.M. Estradiol prevents kainic acid-induced neuronal loss in the rat dentate gyrus. Neuroreport. 9:1998;3075-3079.
2. Beal M.F. Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta. 1366:1998;211-223.
3. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51:1997;535-541.
4. Behl C., Widmann M., Trapp T., Holsboer F. 17beta-estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216:1995;473-482.
5. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol. Cell. Neurosci. 5:1994;303-308.
6. Chernayaev G.A., Barkova T.I., Egorova V.V., Sorokina I.B., Ananchenko S.N., Mataradze G.D., Sokolova N.A., Rozen V.B. A series of optical structural and isomeric analogs of estradiol: a comparative study of the biological activity and affinity to cytosol receptor of rabbit uterus. J. Steroid Biochem. 6:1975;1483-1488.
7. Du C., Hu R., Csernansky C.A., Hsu C.Y., Choi D.W. Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis? J. Cereb. Blood Flow Metab. 16:1996;195-201.
8. Dubal D.B., Kashon M.L., Pettigrew L.C., Ren J.M., Finklestein S.P., Rau S.W., Wise P.M. Estradiol protects against ischemic injury. J. Cereb. Blood Flow Metab. 18:1998;1253-1258.
9. +: implications for neurodegeneration. J. Neurochem. 63:1994;584-591.
10. Dykens J.A. Mitochondrial and free radical production and the etiology of neurogenerative disease. Beal M.F., Bodis-Wollner I., Howell N. Neurodegenerative Diseases: Mitochondria and Free Radicals in Pathogenesis. 1997;29-55 Wiley, New York.
11. Dykens J.A. Free radicals and mitochondrial dysfunction in excitotoxicity and neurodegenerative diseases. Koliatos V.E., Ratan V.V. Cell Death and Diseases of the Nervous System. 1999;45-68 Humana Press, New Jersey.
12. Dykens J.A., Stern A., Trenkner E. Mechanism of kainite toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49:1987;1222-1228.
13. Dykens J.A., Stout A.K. Assessment of mitochondrial membrane potential in situ using single potentiometric dyes and a novel fluorescence resonance energy transfer technique. Meth. Cell Biol. 65:2001;285-309.
14. Edgren R.A., Jones R.C. An anti-estradiol effect of ent-estadiol-17beta (1-estradiol). Steriods. 14:1969;335-341.
15. Fink S.L., Ho D.Y., Sapolsky R.M. Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture. Exp. Neurol. 138:1996;298-304.
16. Finucare F.F., Madans J.H., Bush T.L., Wolf P.H., Kleinman J.C. Decreased risk of stroke among postmenopausal harmone users.Results from a national cohort. Arch Interm Med. 153:1993;73-79.
17. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 63:2001;29-60.
18. Goodman Y., Bruce A.J., Cheng B., Mattson M.P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
19. Green P.S., Bishop J., Simpkins J.W. 17α-estradiol exerts neuroprotective effects in SK-N-SH cells. J. Neurosci. 17:1997;511-515.
20. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem. Mol. Biol. 63:1997;229-235.
21. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathionine. Neuroscience. 84:1998;7-10.
22. Green P.S., Simpkins J.W. Neuroprotective effects of estrogens: potential mechanism of action. Int. J. Dev. Neurosci. 18:2000;347-358.
23. Green P.S., Yang S.H., Nilsson K.R., Kumar A.S., Covey D.F., Simpkins J.W. The nonfeminizing enantiomer of 17beta-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology. 142:2001;400-406.
24. Hansford R.G. Relation between mitochondrial calcium transport and control of energy metabolism. Rev. Physiol. Biochem. Pharmacol. 102:1985;1-72.
25. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurology. 48:1997;1517-1521.
26. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
27. Lee S.J., McEwen B.S. Neurotropic and neuroprotective actions of estrogens and their therapeutic implications. Ann. Rev. Pharmacol. Toxicol. 41:2001;569-591.
28. Lemasters J.J., Qian T., Bradham C.A., Brenner D.A., Cascio W.E., Trost L.C., Nishimura Y., Nieminen A.L., Herman B. Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death. J. Bioenerg. Biomembr. 31:1999;305-319.
29. Marder K., Tang M.X., Alfaro B., Mejia H., Cote L., Jacobs D., Stern Y., Sano M., Mayeux R. Postmenopausal estrogen use and Parkinson's disease with and without dementia. Neurology. 50:1998;1141-1143.
30. Mattson M.P., Robinson N., Guo Q. Estrogens stabilize mitochondrial function and protect neural cells against the pro-apoptotic action of mutant presenilin-1. Neuroreport. 8:1997;3817-3821.
31. Moosmann B., Behl C. The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA. 96:1999;8867-8872.
32. Murphy A.N., Fiskum G., Beal M.F. Mitochondria in neurodegeneration: bioenergetic function in cell life and death. J Cereb. Blood Flow Metab. 19:1999;231-245.
33. Nakamizo T., Urushitani M., Inoue R., Shinohara A., Sawada H., Honda K., Kihara T., Akaike A., Shimohama S. Protection of cultured spinal motor neurons by estradiol. Neuroreport. 11:2000;3493-3497.
34. Nilson, J., Brinton, R.D., 2001. Mitochondrial mechanisms of estradiol-mediated neuroprotection. Abstract, Society for Neuroscience.
35. Payne D.W., Katzenellenbogen J.A. Binding specificity of rat alpha-fetoprotein for a series of estrogen derivatives: studies using equilibrium and nonequilibrium binding techniques. Endocrinology. 105:1979;743-753.
36. Pike C. Estrogen modulates neuronal Bcl-xl expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J. Neurochem. 72:1999;1552-1563.
37. Saunders-Pullman R., Godon-Elliott J., Parides M., Fahn S., Saunders H.R., Bressman S. The effect of estrogen replacement on early Parkinson's disease. Neurology. 52:1999;1417-1421.
38. Sawada H., Ibi M., Kihara T., Urushitani M., Akaike A., Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J. Neurosci. Res. 54:1998;707-719.
39. Sawada H., Ibi M., Kihara T., Urushitani M., Honda K., Nakanishi M., Akaike A., Shimohama S. Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J. 14:2000;1202-1214.
40. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens may reduce mortality and ischaemic damage caused by middle cerebral artery occlusion in the female rat. J. Neurosurg. 87:1997;724-730.
41. Tang M.X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
42. Terenius L. Differential inhibition in vitro of 17beta-estradiol binding in the mouse uterus and vagina by optical antipodes of estrogens. Mol. Pharmacol. 4:1968;301-310.
43. Terenius L. The Allen-Doisy test for estrogens reinvestigated. Steroids. 17:1971;653-661.
44. Wang J., Green P.S., Simpkins J.W. Estradiol protects against ATP depletion, mitochondrial membrane potential decline and the generation of reactive species induced by 3-nitropropionic acid in SK-N-SH human neuroblastoma cells. J. Neurochem. 77:2001;804-811.
45. Yang S.H., Shi J., Day A.L., Simpkins J.W. Estradiol exerts neuroprotective effects when administered after ischaemic insult. Stroke. 31:2000;745-749.
46. Zheng J., Ramirez V.D. Purification and identification of an estrogen binding protein from rat brain: oligomycin sensitivity-conferring protein (OSCP), a subunit of mitochondrial F0F1-ATP synthase/ATPase. J Steroid Biochem. Mol. Biol. 68:1999;65-75.
47. + -ATPase of porcine cortex. Eur. J. Pharmacol. 368:1999;95-102.